HopeStage
Back to all studies
RecruitingNCT06994338

Tirzepatide for alcohol use and weight

About this title

Tirzepatide for Alcohol Use Disorder

Read the official source — NCT06994338
Medication studyAges 21–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 65 years.

Listed locations
Los AngelesSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 6, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
42
Sponsor
University of Southern California
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 21 Years to 65 Years
Official registry ID
NCT06994338
Official title
Show the full official title

Phase II Evaluation of Tirzepatide in Adults With Alcohol Use Disorder and Overweight or Obesity

Recruitment & locations

Currently recruiting

Los Angeles

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Southern California, a university.

Does this study involve medication?

Yes. The study involves medication, including Tirzepatide and Placebo injections.

Who can participate?

Listed age limits: 21 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies